Article
MDK promotes M2 macrophage polarization to remodel the tumour microenvironment in clear cell renal cell carcinoma
6 Aug 2024
Abstract excerpt
The efficacy of immunotherapy for clear cell renal cell carcinoma (ccRCC), especially advanced ccRCC, is limited, presenting a clinical challenge. This limitation is closely tied to the immune regulation network. Understanding the heterogeneity of the tumour microenvironment (TME) is crucial for developing advanced ccRCC therapies. Using publicly available ccRCC data (scRNA-seq, bulk RNA-seq, and somatic mutation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
